← All trials
NCT04872881
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2021
- Primary completion
- Aug 1, 2021
- Completion date
- Oct 1, 2021
- First posted
- May 5, 2021
- Last posted
- May 5, 2021
- Enrollment
- 52
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Izmir Bozyaka Training and Research HospitalLead sponsor
- Izmir Bozyaka Training and Research HospitalReponsible party - principal investigator
- University of HeidelbergStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.